Gas exchange in stable patients with moderate-to-severe lung disease from cystic fibrosis

被引:18
|
作者
Soni, Rajeev [1 ]
Dobbin, Catherine J. [2 ]
Milross, Maree A. [2 ]
Young, Iven H. [2 ]
Bye, Peter P. T. [2 ]
机构
[1] Gosford Hosp, Dept Resp Med, Gosford, NSW 2250, Australia
[2] Royal Prince Alfred Hosp, Dept Resp Med, Sydney, NSW 2050, Australia
关键词
cystic fibrosis; gas exchange; MIGET;
D O I
10.1016/j.jcf.2007.11.003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Studies using the multiple inert gas elimination technique (MIGET) to characterise the mechanisms of impaired gas exchange in CF, provide conflicting results on the importance of ventilation-perfusion (V-A/Q) inequality over shunt. We hypothesise that the mechanisms of gas exchange abnormality have changed with changing CF management over the last two decades. Methods: Detailed gas exchange was evaluated by MIGET with venous sampling in stable patients, age>20 years, FEV1% predicted <= 50. Results: Fifteen (14 male) subjects were studied with a mean +/- SD age 28.1 +/- 8.4 years, FEV1% 32.6 +/- 10.3 TLC% 111.5 +/- 12.9, NO, 9.3 +/- 1.3 kPa, (69.5 +/- 9.6 mm Hg), and PaCO2 6.2 +/- 0.7 kPa, (45.9 +/- 5.3 mm Hg). The predominant gas exchange abnormality was V-A/Q inequality with a log SD of the distributions Of Perfusion 0.91 +/- 0.30 and of ventilation 0.60 +/- 0.14. Unimodal distributions were seen in nine subjects, a low V-A/Q mode in five and one subject had a bimodal distribution, mean intrapulmonary shunt was negligible. Conclusions: Subjects had a lower FEV1% by comparison with previously published studies and demonstrated severe V-A/Q inequality and negligible shunt. This Suggests a low degree of complete obstruction of airways in adults with CF and severe stable Pulmonary disease. The primary mechanism of hypoxaemia in CF Subjects reaching adulthood today appears to have changed with modern management over the last two decades. (C) 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:285 / 291
页数:7
相关论文
共 50 条
  • [1] Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease
    Spicuzza, Lucia
    Parisi, Giuseppe Fabio
    Tardino, Lucia
    Ciancio, Nicola
    Nenna, Raffaella
    Midulla, Fabio
    Leonardi, Salvatore
    JOURNAL OF BREATH RESEARCH, 2018, 12 (02)
  • [2] Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
    Bacci, Giovanni
    Taccetti, Giovanni
    Dolce, Daniela
    Armanini, Federica
    Segata, Nicola
    Di Cesare, Francesca
    Lucidi, Vincenzina
    Fiscarelli, Ersilia
    Morelli, Patrizia
    Casciaro, Rosaria
    Negroni, Anna
    Mengoni, Alessio
    Bevivino, Annamaria
    MICROORGANISMS, 2020, 8 (07) : 1 - 18
  • [3] AZTREONAM LYSINE INHALATION SOLUTION STABILISES LUNG FUNCTION DECLINE IN PATIENTS WITH CYSTIC FIBROSIS AND MODERATE TO SEVERE LUNG DISEASE
    Chadwick, H. K.
    White, H.
    Shaw, N.
    Etherington, C.
    Clifton, I
    Pollard, K.
    Whitaker, P.
    Peckham, D.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 331 - 331
  • [4] Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
    Pfleger, Andreas
    Steinbacher, Michael
    Weinhandl, Elisabeth
    Wagner, Marlies
    Eber, Ernst
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [5] rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease
    Christopher, F
    Chase, D
    Stein, K
    Milne, R
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (06) : 415 - 426
  • [6] Short-term effects of chest physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
    Steinbacher, M.
    Pfleger, A.
    Weinhandl, E.
    Wagner, M.
    Eber, E.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (19-20) : 658 - 659
  • [7] Improved Pulmonary Function Testing in Cystic Fibrosis Patients With Moderate/Severe Obstructive Lung Disease Following Sinus Surgery
    Khalfoun, Sabrina
    Tumin, Dmitry
    Lind, Meredith
    Sheikh, Shahid
    Ghossein, Maroun
    Hayes, Don, Jr.
    Kirkby, Steven
    CHEST, 2016, 150 (04) : 1130A - 1130A
  • [8] Gas Exchange in Disease: Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, and Interstitial Lung Disease
    Young, Iven H.
    Bye, Peter T. P.
    COMPREHENSIVE PHYSIOLOGY, 2011, 1 (02) : 663 - 697
  • [9] DISEASE MODULATION BY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR IN CYSTIC FIBROSIS PATIENTS WITH SEVERE LUNG DISEASE
    Wright, E.
    Megram, E.
    Vardon, P.
    Cobb, R.
    Burgess, K.
    Moore, V
    Loel, F.
    Smith, D.
    Tay, G.
    France, M.
    Reid, D.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S221 - S222
  • [10] DIFFERENTIAL GENE EXPRESSION IN LUNG EPITHELIAL CELLS FROM CYSTIC FIBROSIS PATIENTS WITH MILD OR SEVERE LUNG DISEASE
    Srivastava, M.
    Eidelman, O.
    Huang, W.
    Torosyan, Y.
    Joswik, C.
    Mogayzel, P. J.
    Zeitlin, P.
    Pollard, H. B.
    PEDIATRIC PULMONOLOGY, 2009, : 267 - 268